Israel Englander’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Israel Englander’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,036	Closed	-$496K	–	4003
2015 Q2	$496K	Buy	+12,036	New	+$431K	﹤0.01%	2639
2015 Q1	–	Sell	-86,969	Closed	-$2.79M	–	4486
2014 Q4	$2.79M	Buy	86,969 +1,846	+2%	+$53.4K	0.01%	1742
2014 Q3	$2.39M	Buy	+85,123	New	+$2.59M	0.01%	1751
2014 Q2	–	Sell	-10,000	Closed	-$277K	–	4223
2014 Q1	$277K	Buy	+10,000	New	+$262K	﹤0.01%	2981

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Israel Englander's BRLI Position: Q3 2015 in Review

Israel Englander sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 12,036 shares — an estimated $496K sold.

Israel Englander first reported a position in BRLI in Q1 2014 and held it in 4 quarters. The position peaked at $2.79M in Q4 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Israel Englander reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Israel Englander sold 12,036 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $496K.
Israel Englander first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 4 quarters.
Israel Englander's BIO-REFERENCE LABS INC-NEW- position peaked at $2.79M in Q4 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.